Variant report
Variant | nsv594746 |
---|---|
Chromosome Location | chr4:85083860-85089168 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2868877 | chr4:85083860-85083861 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs573927725 | chr4:85083889-85083890 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs542469393 | chr4:85083905-85083906 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs9992688 | chr4:85083974-85083975 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs371071589 | chr4:85083992-85083993 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192605664 | chr4:85084004-85084005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs544948094 | chr4:85084075-85084076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs560405825 | chr4:85084080-85084081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373054450 | chr4:85084104-85084105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147133136 | chr4:85084108-85084109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542888543 | chr4:85084115-85084116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs115237775 | chr4:85084133-85084134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs373108470 | chr4:85084220-85084221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs550860037 | chr4:85084245-85084246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs145311272 | chr4:85084369-85084370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs184273217 | chr4:85084388-85084389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189093159 | chr4:85084410-85084411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs6843857 | chr4:85084417-85084418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532538201 | chr4:85084465-85084466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs6820390 | chr4:85084480-85084481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547735419 | chr4:85084608-85084609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111529446 | chr4:85084609-85084610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs370391462 | chr4:85084620-85084621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530503857 | chr4:85084626-85084627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536446387 | chr4:85084631-85084632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181337510 | chr4:85084636-85084637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17008219 | chr4:85084658-85084659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186158668 | chr4:85084697-85084698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189878424 | chr4:85084698-85084699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537513289 | chr4:85084727-85084728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75303506 | chr4:85084765-85084766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201674018 | chr4:85084767-85084768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576417989 | chr4:85084768-85084769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs77449802 | chr4:85084769-85084770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74462195 | chr4:85084770-85084771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs397994321 | chr4:85084782-85084783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs377365339 | chr4:85084837-85084838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs72945716 | chr4:85084871-85084872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371380736 | chr4:85084927-85084928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577525899 | chr4:85084973-85084974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs180766237 | chr4:85085025-85085026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs151180113 | chr4:85085026-85085027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572396622 | chr4:85085046-85085047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140199298 | chr4:85085069-85085070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs561028570 | chr4:85085095-85085096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531556274 | chr4:85085098-85085099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543502633 | chr4:85085114-85085115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11397167 | chr4:85085139-85085140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34958308 | chr4:85085140-85085141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565391186 | chr4:85085159-85085160 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Prostate cancer | 16573809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:85080400-85084000 | Enhancers | Fetal Intestine Small | intestine |
2 | chr4:85083200-85086400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr4:85083400-85084000 | Enhancers | Fetal Intestine Large | intestine |
4 | chr4:85083600-85084000 | Bivalent Enhancer | Dnd41 | blood |
5 | chr4:85085000-85085400 | Enhancers | Fetal Lung | lung |
6 | chr4:85086400-85086600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr4:85086400-85086600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
8 | chr4:85086400-85086800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr4:85086600-85088600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
10 | chr4:85086600-85088600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
11 | chr4:85088600-85089200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr4:85088600-85089400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |